Drug Trial Radar · NCT00958581
Tranexamic Acid (TXA) Versus Epsilon Aminocaproic Acid (EACA) Versus Placebo for Spine Surgery
Last checked: Nov 20, 2026Latest source record: Jan 17, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
177
Actual
Start
Dec 2008
Primary completion
Sep 2012
Study completion Sep 2012
Sponsor
- Lead sponsor
- NYU Langone HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 13, 2009
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 10 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) have been reported to reduce blood loss in the cardiac surgery literature but they have not been reported in use head-to-head in the orthopedic surgery literature. In a randomized, double-blind, prospective study we believe that TXA will be more effective than both EACA and placebo at reducing blood loss for corrective spinal surgery.
Conditions
- Scoliosis
Interventions
Tranexamic AcidDrug
For TXA, the loading dose is 10mg/kg infused over 15 minutes, while the maintenance dose is 1/mg/kg hr.
Normal SalineDrug
Normal saline of same volume as the intervention group will be given as the intervention group as a loading dose and maintenance dose.
Epsilon aminocaproic acidDrug
For EACA, the loading dose is 100mg/kg infused over 15 minutes, while the maintenance dose is 10mg/kg hr.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Blood Loss Over Course of Stay (Intraoperative and Postoperatively Until Discharge)Time frame: 1 Week
Locations
1 site in 1 country. Site status is shown where the registry gives one.
New York University School of Medicine - Department of Orthopaedic Surgery - Spine
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.